SHARE

Gilead Sciences, Inc. (GILD) recently declared that John F. Milligan, PhD, Gilead’s President and Chief Executive Officer, and Robin L. Washington, Gilead’s Executive Vice President and Chief Financial Officer, will take part in a fireside chat at the RBC Capital Markets 2017 Global Healthcare Conference in New York on Wednesday, February 22 at 9:30 a.m. Eastern Time.

The audio portion of the fireside chat will be accessible live through the company’s Shareholders page at www.gilead.com/shareholders. Please connect to the company’s website at least 15 minutes before the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.

Gilead Sciences, Inc. (GILD) declared its results of operations for the fourth quarter and full year 2016. Total revenues for the fourth quarter of 2016 were $7.3 billion, contrast to $8.5 billion for the same period in 2015. Net income for the fourth quarter of 2016 was $3.1 billion, or $2.34 per diluted share, contrast to $4.7 billion, or $3.18 per diluted share for the same period in 2015. Non-GAAP net income, which excludes amounts related to acquisition-related, up-front collaboration, stock-based compensation and other expenses, for the fourth quarter of 2016 was $3.6 billion, or $2.70 per diluted share, contrast to $4.9 billion, or $3.32 per diluted share for the same period in 2015.

Full year 2016 total revenues were $30.4 billion, contrast to $32.6 billion for 2015. Net income for 2016 was $13.5 billion, or $9.94 per diluted share, contrast to $18.1 billion, or $11.91 per diluted share for 2015. Non-GAAP net income for 2016, which excludes amounts related to acquisition-related, up-front collaboration, stock-based compensation and other expenses, was $15.7 billion, or $11.57 per diluted share, contrast to $19.2 billion, or $12.61 per diluted share for 2015.

 

 

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here